Roche

Roche gets European approval for Tecentriq combo vs. lung cancer
Reuters
Fri, 03/8/19 - 10:12 am
Roche
Europe
Tecentriq
Avastin
lung cancer
metastatic non-squamous non-small cell lung cancer
Spark bidding war drove Roche bid up by $2.1 billion
BioCentury
Thu, 03/7/19 - 09:46 pm
Spark Therapeutics
Roche
M&A
Roche Study Shows AI Can Detect Severity of Diabetic Macular Edema
BioSpace
Thu, 03/7/19 - 09:56 am
artificial intelligence
Roche
Genentech
telemedicine
diabetic macular edema
devices
Genentech Submits sNDA For Venclexta and Gazyva Combo for Chronic Lymphocytic Leukemia
CP Wire
Thu, 03/7/19 - 09:53 am
Genentech
Roche
AbbVie
chronic lymphocytic leukemia
Gazyva
Venclexta
Genentech Submits sNDA For Venclexta and Gazyva Combo for Chronic Lymphocytic Leukemia
Thu, 03/7/19 - 09:35 am
Genentech
Roche
AbbVie
chronic lymphocytic leukemia
Gazyva
Venclexta
Top 10 drugs losing exclusivity in 2019
Fierce Pharma
Tue, 03/5/19 - 09:40 am
market exclusivity
patents
Rituxan
Lyrica
Herceptin
Avastin
Epclusa
Harvoni
Pfizer
Roche
Gilead Sciences
Amgen
GSK
Allergan
Individor
Sanofi, Bayer and Roche execs underscore the value of digital therapeutics
MedCity
Sat, 03/2/19 - 12:47 pm
digital therapeutics
Sanofi
Bayer
Roche
Roche wins US approval of more convenient Herceptin
Biopharma Dive
Sat, 03/2/19 - 12:03 am
Roche
Herceptin
breast cancer
Big Pharma aces brand valuations for 2019, with Roche once again leading the way
Fierce Pharma
Wed, 02/27/19 - 11:03 am
brand valuation
Roche
Celgene gets fast FDA review of Revlimid combo in lymphoma
Pharmaforum
Wed, 02/27/19 - 10:49 am
Celgene
Revlimid
FDA
Roche
Rituxan
priority review
Can Roche’s little tech startup help the FDA change clinical trials?
Stat
Mon, 02/25/19 - 11:34 pm
FDA
Roche
clinical trials
Flatiron Health
Roche Bets $4.8B on Spark Therapeutics and the Future of Gene Therapy
Xconomy
Mon, 02/25/19 - 10:00 am
Roche
gene therapy
Spark Therapeutics
M&A
IP trouble defers launch of Novo's long-acting hemophilia therapy
Endpoints
Wed, 02/20/19 - 10:03 am
Novo Nordisk
Eseproct
hemophilia
Roche
Hemlibra
2 Pharma Stocks in the Middle of an Oncology Sales Explosion
Motley Fool
Tue, 02/19/19 - 08:01 pm
oncology
Roche
AbbVie
AstraZeneca
As generic competition stutter sales of top oncology drugs, Roche secures speedy review for pair of experimental cancer offerings
Endpoints
Tue, 02/19/19 - 12:15 pm
Roche
Seattle Genetics
generics
antibody-drug conjugate
polatuzumab vedotin
relapsed or refractory diffuse large B-cell lymphoma
entrectinib
solid tumors
Executive Provides Mentorship and Promotes Diversity at Genentech
BioSpace
Mon, 02/18/19 - 07:44 pm
diversity
Genentech
Roche
Layoffs Hit California Biopharma Companies
BioSpace
Mon, 02/18/19 - 11:49 am
layoffs
Roche
Genentech
Pfizer
Aduro BioTech
Theravance
Merck
Hurricanes, droughts, and wildfires: How biopharma is girding for climate change
Stat
Fri, 02/15/19 - 10:29 am
climate change
natural disasters
tropical diseases
Takeda
AbbVie
Roche
Pharma companies clear the R&D decks in Q4
Pharmaforum
Mon, 02/11/19 - 12:20 pm
R&D
GSK
Sanofi
Eli Lilly
Roche
Gilead Sciences
Genentech Plans Legal Battle to Protect Esbriet from Generic Competition
BioSpace
Tue, 02/5/19 - 11:19 pm
Genentech
Roche
idiopathic pulmonary fibrosis
Esbriet
generics

Pages